287 related articles for article (PubMed ID: 28366726)
21. Updates on artemisinin: an insight to mode of actions and strategies for enhanced global production.
Pandey N; Pandey-Rai S
Protoplasma; 2016 Jan; 253(1):15-30. PubMed ID: 25813833
[TBL] [Abstract][Full Text] [Related]
22. [Antitumor activities of 4 derivatives of artemisic acid and artemisinin B in vitro].
Sun WC; Han JX; Yang WY; Deng DA; Yue XF
Zhongguo Yao Li Xue Bao; 1992 Nov; 13(6):541-3. PubMed ID: 1302444
[TBL] [Abstract][Full Text] [Related]
23. Artesunate in the treatment of metastatic uveal melanoma--first experiences.
Berger TG; Dieckmann D; Efferth T; Schultz ES; Funk JO; Baur A; Schuler G
Oncol Rep; 2005 Dec; 14(6):1599-603. PubMed ID: 16273263
[TBL] [Abstract][Full Text] [Related]
24. Dihydroartemisinin: A Potential Natural Anticancer Drug.
Dai X; Zhang X; Chen W; Chen Y; Zhang Q; Mo S; Lu J
Int J Biol Sci; 2021; 17(2):603-622. PubMed ID: 33613116
[TBL] [Abstract][Full Text] [Related]
25. Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds.
Lai H; Sasaki T; Singh NP
Expert Opin Ther Targets; 2005 Oct; 9(5):995-1007. PubMed ID: 16185154
[TBL] [Abstract][Full Text] [Related]
26. Factors determining sensitivity or resistance of tumor cell lines towards artesunate.
Sertel S; Eichhorn T; Sieber S; Sauer A; Weiss J; Plinkert PK; Efferth T
Chem Biol Interact; 2010 Apr; 185(1):42-52. PubMed ID: 20144594
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxicity of 35 medicinal plants from Sudan towards sensitive and multidrug-resistant cancer cells.
Saeed ME; Abdelgadir H; Sugimoto Y; Khalid HE; Efferth T
J Ethnopharmacol; 2015 Nov; 174():644-58. PubMed ID: 26165828
[TBL] [Abstract][Full Text] [Related]
28. Artemisinin and its derivatives: a potential treatment for leukemia.
Lam NS; Long X; Wong JW; Griffin RC; Doery JCG
Anticancer Drugs; 2019 Jan; 30(1):1-18. PubMed ID: 30540593
[TBL] [Abstract][Full Text] [Related]
29. Pharmacodynamic interaction between atovaquone and other antimalarial compounds against Plasmodium falciparum in vitro.
Lütgendorf C; Rojanawatsirivet C; Wernsdorfer G; Sirichaisinthop J; Kollaritsch H; Wernsdorfer WH
Wien Klin Wochenschr; 2006; 118(19-20 Suppl 3):70-6. PubMed ID: 17131244
[TBL] [Abstract][Full Text] [Related]
30. Artemisinin and its derivatives: a promising cancer therapy.
Kiani BH; Kayani WK; Khayam AU; Dilshad E; Ismail H; Mirza B
Mol Biol Rep; 2020 Aug; 47(8):6321-6336. PubMed ID: 32710388
[TBL] [Abstract][Full Text] [Related]
31. Clinical development of combination strategies in immunotherapy: are we ready for more than one investigational product in an early clinical trial?
Perez-Gracia JL; Berraondo P; Martinez-Forero I; Alfaro C; Suarez N; Gurpide A; Sangro B; Hervas-Stubbs S; Ochoa C; Melero JA; Melero I
Immunotherapy; 2009 Sep; 1(5):845-53. PubMed ID: 20636027
[TBL] [Abstract][Full Text] [Related]
32. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells.
Shuhendler AJ; Cheung RY; Manias J; Connor A; Rauth AM; Wu XY
Breast Cancer Res Treat; 2010 Jan; 119(2):255-69. PubMed ID: 19221875
[TBL] [Abstract][Full Text] [Related]
33. Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing.
Augustin Y; Staines HM; Krishna S
Pharmacol Ther; 2020 Dec; 216():107706. PubMed ID: 33075360
[TBL] [Abstract][Full Text] [Related]
34. [Experimental studies of antitumor effect of artesunate on liver cancer].
Wang Q; Wu LM; Li AY; Zhao Y; Wang NP
Zhongguo Zhong Yao Za Zhi; 2001 Oct; 26(10):707-8, 720. PubMed ID: 12776323
[TBL] [Abstract][Full Text] [Related]
35. Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins.
Xiao SH
Acta Trop; 2005; 96(2-3):153-67. PubMed ID: 16112072
[TBL] [Abstract][Full Text] [Related]
36. Collateral sensitivity of natural products in drug-resistant cancer cells.
Efferth T; Saeed MEM; Kadioglu O; Seo EJ; Shirooie S; Mbaveng AT; Nabavi SM; Kuete V
Biotechnol Adv; 2020; 38():107342. PubMed ID: 30708024
[TBL] [Abstract][Full Text] [Related]
37. Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts.
Klement G; Huang P; Mayer B; Green SK; Man S; Bohlen P; Hicklin D; Kerbel RS
Clin Cancer Res; 2002 Jan; 8(1):221-32. PubMed ID: 11801563
[TBL] [Abstract][Full Text] [Related]
38. Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation.
Nakase I; Lai H; Singh NP; Sasaki T
Int J Pharm; 2008 Apr; 354(1-2):28-33. PubMed ID: 17942255
[TBL] [Abstract][Full Text] [Related]
39. Use of artemisinin and its derivatives to treat HPV-infected/transformed cells and cervical cancer: a review.
Goodrich SK; Schlegel CR; Wang G; Belinson JL
Future Oncol; 2014 Mar; 10(4):647-54. PubMed ID: 24754594
[TBL] [Abstract][Full Text] [Related]
40. Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer Treatment.
Wang Y; Yuan X; Ren M; Wang Z
Am J Chin Med; 2024; 52(1):161-181. PubMed ID: 38328829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
